Single-cell transcriptomic profiling of epidermal growth factor receptor (EGFR)-mutant lung cancers reveals tumor-specific upregulation of BCL2L1 alongside downregulation of myeloid cell leukemia 1 (MCL1), a stoichiometric imbalance that buffers apoptotic susceptibility 57. Here, MCL1 is linked to neoplasm.